RNA Therapy Clinical Trials Market By Modality (RNA interference, Antisense therapy, Messenger RNA, Oligonucleotide, non-antisense, non-RNAi), By Clinical Trials Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Areas (Rare Diseases, Anti-infective, Anticancer, Neurological, Alimentary/Metabolic, Musculoskeletal, Cardiovascular Respiratory, Sensory, Others) - Growth, Share, Opportunities & Competitive Analysis, 2026 - 2034
